Application Methods
The administration of cangrilinide varies depending on the research phase and dosage form.
Clinical Research Dosing Regimens:
Monotherapy: In clinical studies, cangrilinide was administered subcutaneously once weekly, with an exploratory dose range of 0.3 mg to 4.5 mg, escalating to the target dose.
Combination Regimen (CagriSema): A fixed-dose combination regimen with semaglutide was also administered subcutaneously once weekly. Phase III studies evaluated doses including 1.0 mg or 2.4 mg per component. Studies showed dose-proportionate pharmacokinetics, with a half-life of approximately 159-195 hours and a median time to peak plasma concentration of 24-72 hours.
Research-Grade Applications:
When used as a research biochemical reagent, the powder form is generally recommended for long-term storage at -20°C. After reconstitution into a solution, it is recommended to aliquot and store at -80°C or -20°C, avoiding repeated freeze-thaw cycles. Specific dissolution methods should be referred to relevant research literature.
Application Scenarios
Weight Management in Obese and Overweight Individuals: This is the core research direction for cangrilinide. Phase II study data showed that after 26 weeks of treatment, cangrilinide (0.3-4.5 mg) resulted in dose-dependent weight loss (6.0%-10.8%), with the 4.5 mg dose showing better weight loss than once-daily liraglutide 3.0 mg. In the Phase III REDEFINE 1 trial, cangrilinide 2.4 mg monotherapy for 68 weeks resulted in an average weight loss of approximately 11.5%-11.8%.
Glycemic Control and Weight Loss in Type 2 Diabetes Patients: The combination regimen with smegglutide (CagriSema) showed significant reductions in glycated hemoglobin and weight in type 2 diabetes patients, with superior glycemic effect compared to placebo, and safety consistent with previous data on GLP-1 inhibitors. The two may work through a complementary mechanism: smegglutide promotes insulin secretion, while cangrilinide may enhance insulin sensitivity.
Storage Conditions
The storage of carglinide must be strictly determined according to the product form and intended use:
Powder form (research grade): It is recommended to store it sealed, protected from light and moisture at -20°C. Under these conditions, stability can generally be maintained for 1 to 3 years.
Solution form (research grade): Prepared solutions should be aliquoted and stored at -80°C (shelf life approximately 6 months) or -20°C (shelf life approximately 1 month). Repeated freeze-thaw cycles are strictly prohibited. It is recommended to aliquot according to single-use dosage.
Clinical trial preparations: Storage conditions should strictly follow the specific drug instructions or clinical trial protocol requirements.
FAQ
Q: What is the minimum order quantity?
A: The minimum order quantity is 10 vials/set.
Q: How long does it take to ship?
A: In-stock orders will be shipped within 24 hours.
Q: What purity can you provide?
A: Standard purity 99%.
Q: Which courier service do you use?
A: FedEx, DHL, UPS, and postal services are available.
Q: How long does shipping take?
A: Approximately 10-15 days.
Q: Can you provide a COA (Certificate of Account) quality inspection report and HPLC (High-Performance Liquid Chromatography) test report?
A: Yes, all goods undergo professional testing before shipment.
Q: Do you support OEM branding?
A: OEM branding service is supported, subject to minimum order quantity requirements.
Q: How is after-sales service handled?
A: After the customer signs for the goods, if it is confirmed that the quality problem is caused by our production, they can enjoy free replacement or refund. We adhere to a pragmatic and responsible service principle, actively respond to and properly handle all kinds of issues, without shirking responsibility or avoiding problems, and do our best to protect the rights and interests of our customers.
Q: What payment methods are available?
A: We support bank transfer, Bitcoin, Transferwise, and Xoom.
Hot Tags: cagrilintide 5mg/vial is effective in controlling appetite and increasing energy expenditure. cas: 1415456-90-4, China cagrilintide 5mg/vial is effective in controlling appetite and increasing energy expenditure. cas: 1415456-90-4 manufacturers, suppliers, factory
